Newtonville, MA, United States of America

Jitendra D Belani

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Infinity Pharmaceuticals, Inc.. Active years: 2014-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jitendra D Belani. Retrieved from https://idiyas.com/inventor/jitendra-d-belani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2014-2018

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jitendra D Belani: Innovator in Enzymatic Transamination

Introduction

Jitendra D Belani is a notable inventor based in Newtonville, MA (US). He has made significant contributions to the field of enzymatic transamination, holding 2 patents that showcase his innovative work.

Latest Patents

His latest patents include the invention titled "Enzymatic transamination of cyclopamine analogs." This invention relates to the preparation of amino-cyclopamines through the enzymatic transamination of corresponding keto-cyclopamines in the presence of a cofactor and an amino donor. This process highlights the potential for developing new compounds with therapeutic applications.

Career Highlights

Jitendra D Belani is currently associated with Infinity Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is pivotal in exploring new avenues in pharmaceutical chemistry.

Collaborations

Some of his notable coworkers include Brian C Austad and Adilah Bahadoor, who contribute to the collaborative environment that fosters innovation at Infinity Pharmaceuticals.

Conclusion

Jitendra D Belani's contributions to enzymatic transamination and his ongoing work at Infinity Pharmaceuticals underscore his role as a key innovator in the field. His patents reflect a commitment to advancing scientific knowledge and developing new therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…